1. Home/
  2. Compounds/
  3. sirolimus:bortezomib (250:1 mol/mol)

sirolimus:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2sirolimus:bortezomib (250:1 mol/mol)
PharmacoGx sirolimus:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to sirolimus:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA C16orf87 CTRPv2 pan-cancer AAC 0.19 5e-08
mRNA ADAR CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA DDHD1 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA ZNF296 CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA IL21R CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA SP140 CTRPv2 pan-cancer AAC 0.2 9e-08
mRNA PPM1K CTRPv2 pan-cancer AAC 0.2 1e-06
mRNA MBD2 CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA TCF3 CTRPv2 pan-cancer AAC 0.2 8e-07
mRNA BTG2 CTRPv2 pan-cancer AAC 0.2 5e-08
Download CSV